Conversion of once‐daily extended‐release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study
暂无分享,去创建一个
[1] D. Samuel,et al. Improved Survival in Liver Transplant Recipients Receiving Prolonged‐Release Tacrolimus in the European Liver Transplant Registry , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] D. Rush,et al. Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] J. Dumortier,et al. Conversion from twice daily tacrolimus to once daily tacrolimus in long‐term stable liver transplant recipients: A single‐center experience with 394 patients , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] M. Volk,et al. Non-Adherence and Graft Failure in Adult Liver Transplant Recipients , 2013, Digestive Diseases and Sciences.
[5] R. Verbeeck,et al. The revised EMA guideline for the investigation of bioequivalence for immediate release oral formulations with systemic action. , 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[6] B. Koneru,et al. Self‐reported non‐adherence to immune‐suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors , 2012, Clinical transplantation.
[7] D. Thorburn,et al. Renal function, efficacy and safety postconversion from twice‐ to once‐daily tacrolimus in stable liver recipients: an open‐label multicenter study , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[8] H. Metselaar,et al. Optimization of the use of Calcineurin inhibitors in liver transplantation. , 2012, Best practice & research. Clinical gastroenterology.
[9] David W. Johnson,et al. Once-Versus Twice-Daily Tacrolimus , 2011, Drugs.
[10] M. Flynn,et al. Medication Noncompliance and its Implications in Transplant Recipients , 2012, Drugs.
[11] E. Ramos,et al. Successful conversion from twice‐daily to once‐daily tacrolimus in liver transplantation: observational multicenter study , 2012, Clinical transplantation.
[12] F. Gnoato,et al. Adherence in liver transplant recipients , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] G. Gerken,et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice‐daily tacrolimus‐based regimen to once‐daily tacrolimus extended‐release formulation , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[14] B. Krämer,et al. Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] D. Seehofer,et al. Once‐Daily Prolonged‐Release Tacrolimus (ADVAGRAF) Versus Twice‐Daily Tacrolimus (PROGRAF) in Liver Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] N. Ichimaru,et al. Treatment adherence in renal transplant recipients: a questionnaire survey on immunosuppressants. , 2008, Transplantation proceedings.
[17] J. Melancon,et al. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. , 2007, Transplantation.
[18] P. Hayes,et al. Adherence to medication after liver transplantation in Scotland: A pilot study , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] M. Schnitzler,et al. Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Twice Daily Versus Once Daily Dosing , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] B Bunzel,et al. Noncompliance in organ transplant recipients: a literature review. , 2000, General hospital psychiatry.
[21] Randall G. Lee,et al. Banff schema for grading liver allograft rejection: An international consensus document , 1997, Hepatology.